Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,358 | -17,414 | -8,892 | -7,825 | -4,571 |
| Depreciation Amortization | 2 | 4 | 4 | 4 | 4 |
| Accounts payable and accrued liabilities | 2,072 | 2,547 | 36 | N/A | -527 |
| Other Working Capital | 2,640 | 2,891 | 32 | -122 | -385 |
| Other Operating Activity | 4,732 | 4,707 | 2,343 | 1,744 | 1,187 |
| Operating Cash Flow | $-9,914 | $-7,267 | $-6,479 | $-6,200 | $-4,292 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -275 |
| Common Stock Issued | 12,000 | 4,369 | N/A | N/A | 3,111 |
| Common Stock Repurchased | N/A | N/A | N/A | -7,536 | N/A |
| Financing Cash Flow | $12,000 | $4,369 | $N/A | $-7,536 | $2,835 |
| Beginning Cash Position | 4,092 | 6,989 | 13,468 | 27,204 | 28,660 |
| End Cash Position | 6,178 | 4,092 | 6,989 | 13,468 | 27,204 |
| Net Cash Flow | $2,086 | $-2,897 | $-6,479 | $-13,736 | $-1,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,914 | -7,267 | -6,479 | -6,200 | -4,292 |
| Free Cash Flow | -9,914 | -7,267 | -6,479 | -6,200 | -4,292 |